We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Glucose in Dialysis Water in Non-diabetics

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00439023
First Posted: February 22, 2007
Last Update Posted: September 15, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Regional Hospital Holstebro
  Purpose

The purposes are

  1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations of glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and
  2. to analysis the relationship between changes in blood pressure on the one hand and changes in vasoactive hormones on the other

Condition Intervention Phase
Renal Failure, Chronic Procedure: dialysis with glucose in dialysis water Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Glucose in Dialysis Water on Blood Pressure and Vasoactive Hormones in Dialysis Patients

Resource links provided by NLM:


Further study details as provided by Regional Hospital Holstebro:

Primary Outcome Measures:
  • Effect of glucose in dialysis water on blood pressure, insulin and vasoactive hormones [ Time Frame: one week ]

Secondary Outcome Measures:
  • Relationship between changes in blood pressure and changes in hormones during treatment [ Time Frame: one week ]

Enrollment: 18
Study Start Date: May 2006
Study Completion Date: May 2007
Detailed Description:
Measurement of hormones and blood pressure during dialysis treatment.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age > 18 years,
  2. Both men and women,
  3. Dialysis treatment for at least three months

Exclusion Criteria:

  1. Heart failure,
  2. Chronic liver disease,
  3. Diabetes mellitus,
  4. Malignant disease,
  5. Nephrotic syndrome,
  6. Lack of compliance, 7 Unwillingness to participate
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00439023


Locations
Denmark
Holstebro Hospital
Holstebro, Denmark, 7500
Sponsors and Collaborators
Regional Hospital Holstebro
Investigators
Study Chair: Erling B Pedersen, Professor Regional Hospital Holstebro
  More Information

ClinicalTrials.gov Identifier: NCT00439023     History of Changes
Other Study ID Numbers: MED.RES.2007.01.EBP
First Submitted: February 20, 2007
First Posted: February 22, 2007
Last Update Posted: September 15, 2015
Last Verified: September 2007

Keywords provided by Regional Hospital Holstebro:
Chronic renal failure, dialysis, hemodialysis,

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Failure, Chronic
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic